featured
Tralokinumab Plus Topical Corticosteroids for the Treatment of Moderate-to-Severe Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tralokinumab Plus Topical Corticosteroids for the Treatment of Moderate-to-Severe Atopic Dermatitis: Results From the Double-Blind, Randomized, Multicentre, Placebo-Controlled Phase III ECZTRA 3
Br J Dermatol 2020 Sep 30;[EPub Ahead of Print], JI Silverberg, D Toth, T Bieber, AF Alexis, BE Elewski, AE Pink, D Hijnen, TN Jensen, B Bang, CK Olsen, A Kurbasic, S WeidingerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.